Gas6, protein S and galectin-3, the ligands for Mer, have been also described to be frequently overexpressed in tumor tissues of NSCLC [21–23], suggesting that Mer receptor is continuously activated in NSCLC via autocrine and/or paracrine mechanisms. This evidence concerns the gene PROS1 and non-small cell lung carcinoma.